Results 91 to 100 of about 687,796 (199)

PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY AFTER ORTHOTOPIC LIVER TRANSPLANTATION: A SYSTEMATIC REVIEW

open access: yes
Background Progressive multifocal leukoencephalopathy is a demyelinating disease of the nervous system. It is caused by reactivation of the John Cunningham Virus in patients with compromised immune systems.
Katarzyna Mania   +10 more
core   +1 more source

Treatment of progressive multifocal leukoencephalopathy with interleukin 7

open access: yes, 2014
IMPORTANCE: No reliable treatment options are known for progressive multifocal leukoencephalopathy with underlying immunodeficiency. We describe successful compassionate use of recombinant human interleukin 7 in a patient with idiopathic CD4+ T-cell ...
Hirsch, Hans H.   +6 more
core   +1 more source

Posterior fossa tremor induced by HIV-associated progressive multifocal leukoencephalopathy [PDF]

open access: yes, 2005
Sporer, B.   +9 more
core   +1 more source

Progressive Multifocal Leukoencephalopathy: Endemic Viruses and Lethal Brain Disease

open access: yes, 2017
In 1971, the first human polyomavirus was isolated from the brain of a patient who died from a rapidly progressing demyelinating disease known as progressive multifocal leukoencephalopathy. The virus was named JC virus after the initials of the patient.
Sheila A. Haley, Walter J. Atwood
core   +1 more source

Progressive Multifocal Leukoencephalopathy Presenting as Internuclear Ophthalmoplegia

open access: yes, 1996
Internuclear ophthalmoplegia has been a presenting manifestation of numerous diseases including multiple sclerosis (commonly bilateral), brainstem infarction (commonly unilateral), infections, brainstem and fourth ventricular tumors, etc.
Gangadhara Sundar, MD; U. R. Desai, MD; B. Skarf, MD
core  

Clinical and immunologic effects of maraviroc in progressive multifocal leukoencephalopathy

open access: yes, 2015
Progressive multifocal leukoencephalopathy (PML) is a rare but generally fatal disease due to JC virus (JCV) reactivation, mainly occurring in immunosuppressed patients.(1) Therapeutic options are limited to blocking glial cell infection by mirtazapine ...
Middel, Ananja   +7 more
core   +1 more source

Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy

open access: yes, 2011
Natalizumab, a therapy for multiple sclerosis (MS), has been associated with progressive multifocal leukoencephalopathy (PML), a rare opportunistic infection of the CNS associated with the JC virus.
Foley, J. F.   +15 more
core   +1 more source

Progressive multifocal leukoencephalopathy in a lung transplant recipient

open access: yesClinical Case Reports
Key Clinical Message Progressive multifocal leukoencephalopathy (PML) is a rare and fatal demyelinating disease of the central nervous system (CNS). The case we describe highlights the importance of considering a diagnosis of PML early (
Jason Sakizadeh   +2 more
doaj   +1 more source

Progressive multifocal leukoencephalopathy limited to the posterior fossa

open access: yes, 2010
Progressive multifocal leukoencephalopathy (PML) is a rapidly progressive demyelinating disease caused by the reactivation of JC papova virus usually in immunocompromised hosts.(1) The disease is a chronic viral infection resulting in mortality within a ...
Ramli, N.M.   +8 more
core   +1 more source

Milky way sign in progressive multifocal leukoencephalopathy

open access: yesAnnals of Indian Academy of Neurology, 2022
Ayush Agarwal   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy